We appreciate their support.
Geoff Bloom
Partner | Health & Life Sciences, Mills Oakley / Chair, MCCA
Aiden Casey
Director, Vitaponix Australia
Isabella De Sousa
Assistant Director, Office of Drug Control (ODC)
Matthew Hayes
Business Owner, Quan-Tick
Patty Holmes
Industry Advisor, MCCA
Scott Israbhakdi
Senior Compliance Inspector, Office of Drug Control (ODC)
Hoda Nahlous
Partner, Mills Oakley
Avi Rebera
Assistant Secretary, Office of Drug Control and Gene Technology Policy
Jamie Snashall
Consultant
Edwina Vandine
Director, Medicinal Cannabis Section, Office of Drug Control (ODC)
Jackie Wu
Director, Yongji Health
We appreciate their support.
Mark Aiken
CEO, Christina Lake Cannabis Corp
Dr Priya Ayyar
Clinical Lead Doctor, Releaf Clinics
Geoff Bloom
Partner | Health & Life Sciences, Mills Oakley / Chair, MCCA
Rhys Cohen
Senior Policy Officer, Penington Institute
Prof the Hon Martin Foley
Bayside Health - Chair / Vice Chancellor's Professorial Fellow - Monash University / Turner Institute on Brain and Mental Health - Industry Advisory Committee
Deborah Greenbaum
A/g Director - Medicinal Cannabis Regulatory Reforms, Office of Drug Control (ODC)
Patty Holmes
Industry Advisor, MCCA
Sank MacFarlane
CEO & Executive Director, Puro New Zealand
Phoebe Macleod
General Manager, Product & Industry Development, Cannatrek Group
Jason McHeyzer
National Director, Compliance and Rapid Regulatory Response Unit, Ahpra
Colin Nuckolls
Professor and Chief Scientific Officer, Columbia University and Helix Research Foundation
Nicholas Ravenswood
Co-Founder & CSO, Rays Wellness
Avi Rebera
Assistant Secretary, Office of Drug Control and Gene Technology Policy
John Ryan
CEO, Penington Institute
Edwina Vandine
Director, Medicinal Cannabis Section, Office of Drug Control (ODC)